When immune thrombocytopenia gets on your nerves: β2-adrenergic receptor agonists as a potential treatment?
Journal of Thrombosis and Haemostasis · 2023
DOI: 10.1016/j.jtha.2023.04.024 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Rick Kapur. Beteiligte Einrichtung: Sanquin Research, Department of Experimental Immunohematology, Amsterdam and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterda…. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Thrombocytopenia. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sanquin Research, Department of Experimental Immunohematology, Amsterdam and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: r.kapur@sanquin.nl.
Zitieren
APA
Kapur, R. (2023). When immune thrombocytopenia gets on your nerves: β2-adrenergic receptor agonists as a potential treatment?. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.04.024
Vancouver
Kapur R. When immune thrombocytopenia gets on your nerves: β2-adrenergic receptor agonists as a potential treatment?. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.04.024
BibTeX
@article{Kapur2023,
author = {Kapur, Rick},
title = {When immune thrombocytopenia gets on your nerves: β2-adrenergic receptor agonists as a potential treatment?},
journal = {Journal of Thrombosis and Haemostasis},
year = {2023},
doi = {10.1016/j.jtha.2023.04.024}
}
EUVIMED